Glioblastoma Cell States Follow Predictable Patterns
Two studies show glioblastoma cells shift between states along stereotypical paths, offering routes to steer tumours toward less malignant behaviour.
Updated on Nov. 5, 2026 in Cancer
Researchers from EMBL, DKFZ, and the Wellcome Sanger Institute published two studies in Nature showing glioblastoma cell state changes follow predictable patterns. The work also identified regulators that can steer cells toward less malignant states.
Why it matters
Glioblastoma, the most common and deadliest adult brain cancer, is hard to cure because its cells switch between states that help them adapt and escape treatment. Mapping those shifts offers a potential way to limit that adaptability.
The largest glioblastoma molecular atlas to date was built from tumours of 12 patients, and gene regulation was examined in over 1 million patient-derived cells. Whether these cell-state patterns translate into effective treatments remains untested.
The players
European Molecular Biology Laboratory (EMBL)
EMBL is an intergovernmental life sciences research organisation based in Heidelberg, Germany, whose computational team contributed to the study.
German Cancer Research Center (DKFZ)
DKFZ is Germany's largest biomedical research institution, and its gene regulation team took part in the work.
Wellcome Sanger Institute
The Wellcome Sanger Institute is a UK genomics research centre in Hinxton, Cambridgeshire, where the study was conducted.
The details
Glioblastoma tumour cells differ greatly from one another and constantly change behaviour. The team found that cells follow stereotypical paths between states, occupy distinct spatial niches inside tumours, and that this spatial architecture appeared in every tumour studied. Overexpressing the gene MYT1L reduced plasticity and malignancy in patient-derived brain tumour cells, and the findings were confirmed in organoids grown on a three-dimensional scaffold.
Timeline
2026: Nature publication of the glioblastoma plasticity studies
Health Landscape
The work extends single-cell mapping of tumours by moving from describing cell states to identifying regulators that control them. It suggests that cancer plasticity may be a therapeutic target, a shift from purely descriptive atlases toward intervention.
For people living with glioblastoma, this research does not change current treatment today. It points toward future therapies that could make tumour cells less able to adapt, though clinical applications may still be some way off.
The takeaway
Cancer cells that constantly shift their behaviour can outmanoeuvre treatment, so understanding and steering those shifts may be a useful strategy. Readers interested in the science can follow updates on glioblastoma research through the Cancer section.
Further reading
For related context on tumour biology and treatment approaches, explore our Cancer coverage.
